Description
PurvalanolAisapurinederivativeanticancercompoundthatinhibitscyclin-dependentkinases(CDKs).PurvalanolAinducescellcyclearrestandapoptosisinbreastcancercellsandisclinicallyusedtoincreaseefficacyofco-admiNISTeredchemotherapeuticsbyinhibitingbreastcancerresistanceprotein(ABCG2)transport.InADIpose-derivedstemcells,purvalanolAinhibitsCDK1/Cdc2andCDK2/cyclinE,alteringdifferentiationpotential.PurvalanolAalsoinhibitsJAK2/STATactivationandRNApolymeraseIIactivityingastricadenocarcinomacells.Additionally,thiscompounddecreaseshumanT-cellleukemiavirustype1(HTLV-1)proliferation.
References
ObakanP,ArısanED,ÖzfilizP,etal.PurvalanolAisastrongapoptoticinducerviaactivatingpolyaminecatabolicpathwayinMCF-7estrogenreceptorpositivebreastcancercells.MolBiolRep.2014Jan;41(1):145-54.PMID:24190492.
HofmanJ,AhmadimoghaddamD,HahnovaL,etal.OlomoucineIIandpurvalanolAinhibitABCG2transporterinvitroandinsituandsynergisticallypotentiatecytostaticeffectofmitoxantrone.PharmacolRes.2012Mar;65(3):312-9.PMID:22173067.
ParkH,ChoJA,LimEH,etal.CellcycleregulatorsarecriticalformaintainingthedifferentiationpotentialandimmaturityinAdipogenesisofadipose-derivedstemcells.Differentiation.2011Oct;82(3):136-43.PMID:21764208.
IizukaD,OguraA,KuwabaraM,etal.PurvalanolAinducesapoptosisanddownregulationofantiapoptoticproteinsthroughabrogationofphosphorylationofJAK2/STAT3andRNApolymeraseII.AnticancerDrugs.2008Jul;19(6):565-72.PMID:18525315.
AgbottahE,YehWI,BerroR,etal.Twospecificdrugs,BMS-345541andpurvalanolAinduceapoptosisofHTLV-1infectedcellsthroughinhibitionoftheNF-kappaBandcellcyclepathways.AIDSResTher.2008Jun10;5:12.PMID:18544167.